Insider Transactions Reported by 10 Insiders of Nuvectis Pharma, Inc.

Symbol
NVCT on Nasdaq
Location
Fort Lee, NJ

Insiders trading volume in the past year

Nuvectis Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Charles Mosseri 10%+ Owner $20,355,809 +$2,890,311 +17% 23 Oct 2025
RON BENTSUR Chairman & CEO, Director, 10%+ Owner $20,168,285 +$28,600 +0.14% 05 Nov 2025
Enrique Poradosu Chief Science & Business Off $7,701,883 02 Jan 2025
Shay Shemesh Chief Dev. & Ops. Officer $7,640,266 02 Jan 2025
Kenneth Hoberman Director $1,122,370 12 Jun 2025
James F. Oliviero III Director $740,390 12 Jun 2025
Matthew Kaplan Director $728,598 +$64,240 +9.7% 05 Nov 2025
Michael Carson Vice President, Finance $645,969 02 Jan 2025
Juan Sanchez Director $454,986 +$75,270 +20% 05 Nov 2025
Uri Ben-Or Int. Principal Financial Off. $283,471 08 Feb 2022

Recent Insider Transactions by Companies or Individuals for Nuvectis Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.